Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity

NCT01602861 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT01602861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity
Lead sponsor
Odense University Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
April 30, 2021
Enrollment
188 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to renal transplantation